Showing results (161-170 of 226) with videos related to
Sort By:
Pageof 23
Journal of Neurochemistry|December 5, 2012
Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMAMariana Angoa-Pérez, Michael J Kane, Denise I Briggs, et al.Genome Research|April 6, 2018
Optical mapping reveals a higher level of genomic architecture of chained fusions in cancerEva K F Chan, Daniel L Cameron, Desiree C Petersen, et al.European Journal of Human Genetics : EJHG|October 25, 2018
The Medical Genome Reference Bank: a whole-genome data resource of 4000 healthy elderly individuals. Rationale and cohort designPaul Lacaze, Mark Pinese, Warren Kaplan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the Adjuvant Colon Cancer Endpoints data setJoleen Hubbard, David M Thomas, Greg Yothers, et al.NPJ Precision Oncology|June 24, 2021
Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncologyFrank P Lin, Subotheni Thavaneswaran, John P Grady, et al.JAMA Oncology|March 20, 2020
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With OsteosarcomaLisa Mirabello, Bin Zhu, Roelof Koster, et al.Oncoimmunology|April 22, 2020
Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomasAmanda R Dancsok, Dongxia Gao, Anna F Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2011
Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trialsCharles D Blanke, Brian M Bot, David M Thomas, et al.Therapeutic Advances in Medical Oncology|September 4, 2024
Criteria for assessing evidence for biomarker-targeted therapies in rare cancers-an extrapolation frameworkDoah Cho, Sarah J Lord, Robyn Ward, et al.Cancer|February 3, 2011
RECK in osteosarcoma: a novel role in tumour vasculature and inhibition of tumorigenesis in an orthotopic modelJonathan C M Clark, Toru Akiyama, David M Thomas, et al.Pageof 23